Clinical Trial

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Study acronym: PERRAS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-01-04; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2022-07-11
Trial Details
NCT Number NCT05181891
Lead Sponsor Washington State University
Conditions Alcohol Use Disorder (AUD), Nicotine Use Disorder
Enrollment 205 participants
Start Date 2022-07-11
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-06